Stone Ridge Asset Management LLC Gilead Sciences, Inc. Transaction History

Stone Ridge Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $9.32 Million - $11.7 Million	-150,000 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $10.9 Million - $12.6 Million	150,000 New	150,000 $11.5 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $3.71 Million - $4.16 Million	-60,000 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $4.83 Million - $5.34 Million	-67,701 Reduced 53.02%	60,000 $4.63 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $3.39 Million - $3.96 Million	-52,300 Reduced 29.06%	127,701 $9.05 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $7.25 Million - $8.84 Million	-99,500 Reduced 35.6%	180,001 $13.6 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $19.9 Million - $23.3 Million	279,501	279,501 $20 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.